GoHealth Reports Catastrophic 2025 Results, Going Concern Warning, Negative Equity, and Confirmed Nasdaq Delisting Risk
GOCO is trading near its 52-week low of $1.31 (9.9% above the low).
Summary
GoHealth, Inc. reported a massive net loss of $257.1 million for 2025, a 54.7% revenue decline, and a negative stockholders' equity, alongside a going concern warning and confirmed Nasdaq delisting notice.
Key Events · Earnings and Guidance · GOCO
-
Catastrophic Financial Performance
GoHealth, Inc. reported a net loss attributable to the company of $257.1 million for 2025, a significant worsening from a $2.9 million loss in 2024. Net revenues plummeted 54.7% to $361.8 million, and Adjusted EBITDA turned negative to $(35.1) million from $120.3 million in 2024.
-
Going Concern Doubt and Negative Equity
Management identified a significant likelihood of being unable to comply with debt covenants within the next 12 months, raising substantial doubt about the company's ability to continue as a going concern. Total stockholders' equity turned negative to $(62.2) million as of December 31, 2025, from $405.4 million in 2024.
-
Massive Asset Impairment Charges
The company recorded $259.961 million in indefinite and long-lived asset impairment charges in 2025, reflecting a severe reduction in forecasted cash flows and asset values under its updated business plan.
-
Confirmed Nasdaq Delisting Risk
The filing confirms the March 18, 2026 Nasdaq delisting notice for failing to meet the $35 million minimum market value requirement, with a compliance period until September 14, 2026.
Analysis · GOCO · Finance
GoHealth's 2025 annual report reveals a company in severe financial distress, marked by a substantial net loss, a dramatic revenue decline, and negative shareholder equity. The explicit 'going concern' warning, coupled with the confirmed Nasdaq delisting notice and ongoing significant legal challenges, indicates a critical threat to the company's viability. Investors face extreme uncertainty and potential for further value erosion, as the company's strategic pivot and cost-cutting measures appear insufficient to offset the deteriorating financial performance and market pressures.
At the time of this filing, GOCO was trading at $1.44 on NASDAQ in the Finance sector, with a market capitalization of approximately $24.3M. The 52-week trading range was $1.31 to $12.69. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.